EQL Pharma AB
Develops and sells niche generic and specialty medicines, primarily in Nordic markets.
EQL | ST
Overview
Corporate Details
- ISIN(s):
- SE0005497732
- LEI:
- 549300Q8B2D2AE8GCW21
- Country:
- Sweden
- Address:
- Stortorget 1, 222 23 Lund
- Website:
- https://eqlpharma.com/en/
- Sector:
- Manufacturing
Description
EQL Pharma AB is a pharmaceutical company that develops, markets, and sells generic and specialty medicines. The company's strategy centers on identifying and developing "niche generics," which are medically equivalent to originator drugs but face limited competition after patent expiration. Its business operations also include specialty pharmaceuticals and the parallel import of medicines. EQL Pharma emphasizes cost-efficiency and collaborates with a global network of development partners. The company serves pharmacies and hospitals, primarily in the Nordic markets, maintaining a portfolio of marketed products while cultivating an extensive pipeline of new medicines.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-08-18 11:00 |
Valberedningens förslag inför årsstämman i EQL Pharma AB
|
Swedish | 322.2 KB | ||
| 2025-08-18 11:00 |
The Nomination Committee’s proposal for the annual general meeting in EQL Pharm…
|
English | 321.4 KB | ||
| 2025-08-08 07:00 | Swedish | 1.2 MB | |||
| 2025-08-08 07:00 | English | 1.3 MB | |||
| 2025-07-25 08:00 | Swedish | 19.5 MB | |||
| 2025-07-22 10:00 |
Kallelse till årsstämma i EQL Pharma AB
|
Swedish | 281.5 KB | ||
| 2025-07-22 10:00 |
Notice of annual general meeting in EQL Pharma AB
|
English | 287.5 KB | ||
| 2025-05-08 07:00 | Swedish | 1.3 MB | |||
| 2025-05-08 07:00 | English | 1.3 MB | |||
| 2025-03-07 08:30 |
New financial targets for the period 2024/25 – 2028/29
|
English | 351.6 KB | ||
| 2025-03-07 08:30 |
Nya finansiella mål för perioden 2024/25 - 2028/29
|
Swedish | 291.7 KB | ||
| 2025-02-24 09:24 |
Valberedning inför årsstämman 2025
|
Swedish | 352.0 KB | ||
| 2025-02-24 09:24 |
Nomination committee for the 2025 Annual General Meeting
|
English | 216.8 KB | ||
| 2025-02-05 07:00 | Swedish | 1.3 MB | |||
| 2025-02-05 07:00 | English | 1.3 MB |
Automate Your Workflow. Get a real-time feed of all EQL Pharma AB filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for EQL Pharma AB
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for EQL Pharma AB via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-02-17 | christer fåhraeus | Other | Sell | 100,000 | 8,620,000.00 SEK |
Peer Companies
